About 90 percent of people fully inoculated by the Pfizer-BioNTech vaccine are well protected from variants of the novel ...
Researchers have developed a modified version of the CRISPR gene-editing tool that in early laboratory experiments suggests ...
A nanodisc platform that offers a clearer view of how key viral proteins interact with antibodies could lead to better HIV ...
Gene‑edited HPSCs programmed to make therapeutic antibodies and proteins show long‑lasting, boostable immunity in mouse models.
An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...
Axim Biotechnologies Inc. stock grades by Barron's. View AXIM fundamental and sentiment analysis powered by MarketGrader.
A University of Iowa faculty member has won nearly $3 million from the National Institutes of Health to advance biomedical ...
Scientists in China have developed a two-antibody cocktail to treat respiratory syncytial virus, or RSV, that in laboratory ...
A new nanodisc-based platform lets scientists study viral proteins in a form that closely mimics real viruses, revealing how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results